
Preliminary research published in Nature suggests that COVID-19 vaccines, particularly Pfizer and Moderna, may offer unexpected benefits for cancer patients. People with advanced lung or skin cancer who received the vaccine within 100 days of starting immunotherapy lived significantly longer. Researchers found that the mRNA in the vaccines might enhance the immune system’s response to cancer treatments, independent of any virus-related effects.
Trending
- Renewables group Venterra lands £40m amid leadership tensions | Money News
- US reportedly pursuing third oil tanker linked to Venezuela
- Interstellar comet comes closest to Earth – DW – 12/19/2025
- Fears grow over AI bubble – and here are the pressure points that could burst it | Science, Climate & Tech News
- Will tech trump tradition at bakers and biscuit makers?
- Kerstdiner met een kind dat weinig lust: 'De strijd aangaan is een absolute no-go’
- Epidural kit shortage could last until March, regulator says
- Morocco gets off to winning start at Africa Cup of Nations
